1、 FRAZIER S K, HIGGINS J, BUGAISKI A, et al. Adverse reactions to transfusion of blood products and best practices for prevention[J]. Crit Care Nurs Clin North Am, 2017,29(3):271-290. FRAZIER S K, HIGGINS J, BUGAISKI A, et al. Adverse reactions to transfusion of blood products and best practices for prevention[J]. Crit Care Nurs Clin North Am, 2017,29(3):271-290.
2、 THOMAS J, AVIEKO P, OGERO M, et al. Blood transfusion delay and outcome in county hospitals in Kenya[J]. Am J Trop Med Hyg, 2017,96(2):511-517. THOMAS J, AVIEKO P, OGERO M, et al. Blood transfusion delay and outcome in county hospitals in Kenya[J]. Am J Trop Med Hyg, 2017,96(2):511-517.
3、 LACROIX J, HEBERT P C, HUTCHISON J S, et al. Transfusion strategies for patients in pediatric intensive care units[J]. N Engl J Med, 2007,356(16):1609-1619. LACROIX J, HEBERT P C, HUTCHISON J S, et al. Transfusion strategies for patients in pediatric intensive care units[J]. N Engl J Med, 2007,356(16):1609-1619.
4、 NEW H V, HERRYMAN J, BOLTON-MAGGS P H, et al. Guidelines on transfusion for fetuses, neonates and older children[J]. Br J Haematol, 2016, 175(5):784-828. NEW H V, HERRYMAN J, BOLTON-MAGGS P H, et al. Guidelines on transfusion for fetuses, neonates and older children[J]. Br J Haematol, 2016, 175(5):784-828.
5、 袁秋芳. 成分输血在儿童血液疾病治疗中的应用价值[J]. 世界最新医学信息文摘, 2019,19(64):205,7. 袁秋芳. 成分输血在儿童血液疾病治疗中的应用价值[J]. 世界最新医学信息文摘, 2019,19(64):205,7.
6、 SEMPLE J W, REBETZ J, KAPUR R. Transfusion-associated circulatory overload and transfusion-related acute lung injury[J]. Blood, 2019,133(17):1840-1853. SEMPLE J W, REBETZ J, KAPUR R. Transfusion-associated circulatory overload and transfusion-related acute lung injury[J]. Blood, 2019,133(17):1840-1853.
7、 van DEN AKKER T A, GRIMES Z M, FRIEDMAN M T. Transfusion-associated circulatory overload and transfusion-related acute lung injury[J]. Am J Clin Pathol, 2021,156(4):529-539. van DEN AKKER T A, GRIMES Z M, FRIEDMAN M T. Transfusion-associated circulatory overload and transfusion-related acute lung injury[J]. Am J Clin Pathol, 2021,156(4):529-539.
8、 BALLO O, FLECKENSTEIN P, ELADLY F, et al. Reducing the red blood cell transfusion threshold from 8.0 g/dl to 7.0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome[J]. Vox Sang, 2020,115(7):570-578. BALLO O, FLECKENSTEIN P, ELADLY F, et al. Reducing the red blood cell transfusion threshold from 8.0 g/dl to 7.0 g/dl in acute myeloid leukaemia patients undergoing induction chemotherapy reduces transfusion rates without adversely affecting patient outcome[J]. Vox Sang, 2020,115(7):570-578.
9、 LIM A R, KIM J H, HYUN M H, et al. Blood transfusion has an adverse impact on the prognosis of patients receiving chemotherapy for advanced colorectal cancer: experience from a single institution with a patient blood management program[J]. Support Care Cancer, 2022,30(6):5289-5297. LIM A R, KIM J H, HYUN M H, et al. Blood transfusion has an adverse impact on the prognosis of patients receiving chemotherapy for advanced colorectal cancer: experience from a single institution with a patient blood management program[J]. Support Care Cancer, 2022,30(6):5289-5297.
10、 梁明月,骆宏,黄伯泉,等. 2018～2020年广州市采血不足量发生原因分析[J]. 中国输血杂志, 2021,34(5):514-516. 梁明月,骆宏,黄伯泉,等. 2018～2020年广州市采血不足量发生原因分析[J]. 中国输血杂志, 2021,34(5):514-516.
11、 JONSSON A B, GRANHOLM A, RYGARD S L,et al. Lower vs higher transfusion threshold in septic shock patients of different ages: A study protocol[J]. Acta Anaesthesiol Scand, 2019,63(9):1247-1250. JONSSON A B, GRANHOLM A, RYGARD S L,et al. Lower vs higher transfusion threshold in septic shock patients of different ages: A study protocol[J]. Acta Anaesthesiol Scand, 2019,63(9):1247-1250.
12、 YAZER M H, TRIULZI D. AABB red blood cell transfusion guidelines: something for almost everyone[J]. Jama, 2016,316(19):1984-1985. YAZER M H, TRIULZI D. AABB red blood cell transfusion guidelines: something for almost everyone[J]. Jama, 2016,316(19):1984-1985.
13、 KAUFMAN R M, DJULBEGOVIC B, GERNSHEIMER T, et al. Platelet transfusion: a clinical practice guideline from the AABB[J]. Ann Intern Med, 2015,162(3):205-213. KAUFMAN R M, DJULBEGOVIC B, GERNSHEIMER T, et al. Platelet transfusion: a clinical practice guideline from the AABB[J]. Ann Intern Med, 2015,162(3):205-213.
14、 SCHIFFER C A, BOHLKE K, DELANEY M, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline update[J]. J Clin Oncol, 2018,36(3):283-299. SCHIFFER C A, BOHLKE K, DELANEY M, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline update[J]. J Clin Oncol, 2018,36(3):283-299.
15、 TAY J, ALLAN D S, CHATELAIN E, et al. Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase Ⅲ, noninferiority trial[J]. J Clin Oncol, 2020,38(13):1463-1473. TAY J, ALLAN D S, CHATELAIN E, et al. Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase Ⅲ, noninferiority trial[J]. J Clin Oncol, 2020,38(13):1463-1473.
16、 MO Y D, DELANEY M. Transfusion in pediatric patients: review of evidence-based guidelines[J].Clin Lab Med, 2021,41(1):1-14. MO Y D, DELANEY M. Transfusion in pediatric patients: review of evidence-based guidelines[J].Clin Lab Med, 2021,41(1):1-14.
17、 傅钰斌.加强采供血机构贮血发血部门日常管理对血液质量的意义[J]. 现代医院, 2021,21(4):541-543. 傅钰斌.加强采供血机构贮血发血部门日常管理对血液质量的意义[J]. 现代医院, 2021,21(4):541-543.
18、 LI Q, GUAN X, WU P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J]. N Engl J Med, 2020,382(13):1199-1207. LI Q, GUAN X, WU P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia[J]. N Engl J Med, 2020,382(13):1199-1207.
